Chro.50137 | hypothetical protein

  • Computed_GO_Component_IDs:        

  • Computed_GO_Components:        

  • Computed_GO_Function_IDs:        

  • Computed_GO_Functions:        

  • Computed_GO_Process_IDs:        

  • Computed_GO_Processes:        

  • Curated_GO_Component_IDs:        

  • Curated_GO_Components:        

  • Curated_GO_Function_IDs:        

  • Curated_GO_Functions:        

  • Curated_GO_Processes:        

_IDPredictionOTHERSPmTPCS_Position
Chro.50137OTHER0.9586140.0403090.001077
No Results

  • Fasta :-

    >Chro.50137 MKSRQINDLNLMDCWPNDIIYFVRILLLLRGICAELNESIPILKILSRRAQQFLYLESIN LELNKQQLLKRRFTNKFERRLSDYIEKIMNENMVWGYNXAIIKNGKXLVNISKGIKGELN GNQIDENTLFNGFFINLGILVIAILICVEKGYISLDDPICHYWDGFIRYGKRNITLRHVL DHRSGVISFFPKDMGLKELLNYEKMIQIIEDSAPQVPINQITRYNPYFLGWILSELIALL TNQSTTKFIEENIINPFNLSDGIKMYLPDYSLNNDQVSIFQSEKYDETNIGANNNNNKFL FPLFSPRSSSSSSFFAQEEFSSSIMRLSNIKSKLENSNGTQLMNEIKDIIIQKLTPKRIS KEEKEKEKEKEKNINDYNEEDNNDENINIIDFYERYAMVNRKMEFSSISFKQVLEKLKSS DLYKLKNYGYQDFNKTKINLKLSTLEYFFLKPDILDPLIYNSKKLINKWIPPTNGRYTSL SLAKLYNHLIRGEIIGDKLLKQVIKNESITFDNSIEGLILTYGGPRKWSLGFQILECKKI YYHQNNQKDDDQPCFKGIGQSDTGGNLSFCFPEIDLSIAILTNDYVKGSYISQSILRYIL ENFGLYLNNYVPLYFS
  • Download Fasta
  • MitoProt II - v1.101 File : /home/rajan/sadaf/4480_mitoprot/test/303 Sequence name : 303 Sequence length : 616 VALUES OF COMPUTED PARAMETERS Coef20 : 3.706 CoefTot : -0.155 ChDiff : 3 ZoneTo : 7 KR : 2 DE : 0 CleavSite : 0 HYDROPHOBIC SCALE USED GES KD GVH1 ECS H17 : 2.194 2.818 0.554 0.941 MesoH : -0.564 0.453 -0.365 0.300 MuHd_075 : 37.384 15.636 7.186 6.528 MuHd_095 : 5.971 0.439 1.750 0.338 MuHd_100 : 8.722 3.486 0.447 1.955 MuHd_105 : 14.564 6.450 2.356 3.422 Hmax_075 : 2.683 2.683 -2.058 2.707 Hmax_095 : -7.350 -1.225 -3.389 0.840 Hmax_100 : -2.000 -1.900 -4.548 1.560 Hmax_105 : -4.433 1.400 -4.119 1.062 CLASS NOT-MITO MITO(/CHLORO) DFM : 0.9845 0.0155 DFMC : 0.9825 0.0175
  • ##### ProP v.1.0b ProPeptide Cleavage Site Prediction ##### ##### Furin-type cleavage site prediction (Arginine/Lysine residues) ##### 616 Chro.50137 MKSRQINDLNLMDCWPNDIIYFVRILLLLRGICAELNESIPILKILSRRAQQFLYLESINLELNKQQLLKRRFTNKFERR 80 LSDYIEKIMNENMVWGYNXAIIKNGKXLVNISKGIKGELNGNQIDENTLFNGFFINLGILVIAILICVEKGYISLDDPIC 160 HYWDGFIRYGKRNITLRHVLDHRSGVISFFPKDMGLKELLNYEKMIQIIEDSAPQVPINQITRYNPYFLGWILSELIALL 240 TNQSTTKFIEENIINPFNLSDGIKMYLPDYSLNNDQVSIFQSEKYDETNIGANNNNNKFLFPLFSPRSSSSSSFFAQEEF 320 SSSIMRLSNIKSKLENSNGTQLMNEIKDIIIQKLTPKRISKEEKEKEKEKEKNINDYNEEDNNDENINIIDFYERYAMVN 400 RKMEFSSISFKQVLEKLKSSDLYKLKNYGYQDFNKTKINLKLSTLEYFFLKPDILDPLIYNSKKLINKWIPPTNGRYTSL 480 SLAKLYNHLIRGEIIGDKLLKQVIKNESITFDNSIEGLILTYGGPRKWSLGFQILECKKIYYHQNNQKDDDQPCFKGIGQ 560 SDTGGNLSFCFPEIDLSIAILTNDYVKGSYISQSILRYILENFGLYLNNYVPLYFS 640 ................................................................................ 80 ................................................................................ 160 ................................................................................ 240 ................................................................................ 320 ................................................................................ 400 ................................................................................ 480 ................................................................................ 560 ........................................................ 640 Propeptide cleavage sites predicted: Arg(R)/Lys(K): 0 Name Pos Context Score Pred ____________________________v_________________ Chro.50137 2 -----MK|SR 0.074 . Chro.50137 4 ---MKSR|QI 0.113 . Chro.50137 24 DIIYFVR|IL 0.074 . Chro.50137 30 RILLLLR|GI 0.088 . Chro.50137 44 ESIPILK|IL 0.064 . Chro.50137 48 ILKILSR|RA 0.094 . Chro.50137 49 LKILSRR|AQ 0.107 . Chro.50137 65 INLELNK|QQ 0.058 . Chro.50137 70 NKQQLLK|RR 0.059 . Chro.50137 71 KQQLLKR|RF 0.142 . Chro.50137 72 QQLLKRR|FT 0.197 . Chro.50137 76 KRRFTNK|FE 0.072 . Chro.50137 79 FTNKFER|RL 0.112 . Chro.50137 80 TNKFERR|LS 0.216 . Chro.50137 87 LSDYIEK|IM 0.061 . Chro.50137 103 YNXAIIK|NG 0.058 . Chro.50137 106 AIIKNGK|XL 0.064 . Chro.50137 113 XLVNISK|GI 0.075 . Chro.50137 116 NISKGIK|GE 0.060 . Chro.50137 150 ILICVEK|GY 0.063 . Chro.50137 168 YWDGFIR|YG 0.077 . Chro.50137 171 GFIRYGK|RN 0.115 . Chro.50137 172 FIRYGKR|NI 0.112 . Chro.50137 177 KRNITLR|HV 0.200 . Chro.50137 183 RHVLDHR|SG 0.094 . Chro.50137 192 VISFFPK|DM 0.098 . Chro.50137 197 PKDMGLK|EL 0.061 . Chro.50137 204 ELLNYEK|MI 0.071 . Chro.50137 223 PINQITR|YN 0.094 . Chro.50137 247 TNQSTTK|FI 0.088 . Chro.50137 264 NLSDGIK|MY 0.063 . Chro.50137 284 SIFQSEK|YD 0.071 . Chro.50137 298 ANNNNNK|FL 0.079 . Chro.50137 307 FPLFSPR|SS 0.141 . Chro.50137 326 FSSSIMR|LS 0.095 . Chro.50137 331 MRLSNIK|SK 0.067 . Chro.50137 333 LSNIKSK|LE 0.072 . Chro.50137 347 QLMNEIK|DI 0.084 . Chro.50137 353 KDIIIQK|LT 0.060 . Chro.50137 357 IQKLTPK|RI 0.077 . Chro.50137 358 QKLTPKR|IS 0.137 . Chro.50137 361 TPKRISK|EE 0.148 . Chro.50137 364 RISKEEK|EK 0.083 . Chro.50137 366 SKEEKEK|EK 0.072 . Chro.50137 368 EEKEKEK|EK 0.071 . Chro.50137 370 KEKEKEK|EK 0.064 . Chro.50137 372 KEKEKEK|NI 0.067 . Chro.50137 395 IIDFYER|YA 0.117 . Chro.50137 401 RYAMVNR|KM 0.091 . Chro.50137 402 YAMVNRK|ME 0.087 . Chro.50137 411 FSSISFK|QV 0.111 . Chro.50137 416 FKQVLEK|LK 0.064 . Chro.50137 418 QVLEKLK|SS 0.066 . Chro.50137 424 KSSDLYK|LK 0.077 . Chro.50137 426 SDLYKLK|NY 0.072 . Chro.50137 435 GYQDFNK|TK 0.062 . Chro.50137 437 QDFNKTK|IN 0.062 . Chro.50137 441 KTKINLK|LS 0.055 . Chro.50137 451 LEYFFLK|PD 0.058 . Chro.50137 463 PLIYNSK|KL 0.056 . Chro.50137 464 LIYNSKK|LI 0.114 . Chro.50137 468 SKKLINK|WI 0.064 . Chro.50137 476 IPPTNGR|YT 0.107 . Chro.50137 484 TSLSLAK|LY 0.069 . Chro.50137 491 LYNHLIR|GE 0.107 . Chro.50137 498 GEIIGDK|LL 0.065 . Chro.50137 501 IGDKLLK|QV 0.087 . Chro.50137 505 LLKQVIK|NE 0.070 . Chro.50137 526 LTYGGPR|KW 0.087 . Chro.50137 527 TYGGPRK|WS 0.078 . Chro.50137 538 FQILECK|KI 0.063 . Chro.50137 539 QILECKK|IY 0.085 . Chro.50137 548 YHQNNQK|DD 0.069 . Chro.50137 556 DDQPCFK|GI 0.095 . Chro.50137 587 LTNDYVK|GS 0.068 . Chro.50137 597 ISQSILR|YI 0.096 . ____________________________^_________________

  • Fasta :-

    >Chro.50137 ATGAAAAGTAGACAAATAAATGATTTAAATCTAATGGATTGCTGGCCAAATGATATAATA TATTTTGTAAGGATTTTATTGTTATTACGTGGTATATGTGCTGAATTGAATGAGAGTATA CCGATTTTGAAAATATTATCCAGAAGAGCACAACAATTCTTATATTTAGAGTCAATTAAT TTAGAATTAAATAAACAACAGTTATTAAAAAGAAGATTTACAAATAAATTTGAAAGGAGA TTAAGCGATTATATTGAAAAAATAATGAATGAAAATATGGTATGGGGATACAATNNAGCT ATTATAAAGAATGGAAAGNATTTAGTAAATATTTCAAAAGGTATTAAGGGAGAATTAAAT GGAAATCAGATTGATGAAAATACATTATTTAATGGTTTCTTTATCAATCTTGGAATTTTG GTAATTGCAATATTAATATGTGTGGAAAAAGGTTATATATCTCTGGATGATCCAATTTGT CATTATTGGGATGGTTTTATAAGATATGGAAAGAGGAACATAACATTAAGGCATGTGCTT GATCATAGATCTGGTGTAATATCGTTTTTTCCAAAGGATATGGGTTTAAAAGAATTGTTA AATTATGAAAAGATGATCCAAATAATTGAAGATTCTGCTCCACAGGTTCCAATAAATCAA ATTACACGATATAATCCTTATTTTTTAGGTTGGATATTATCAGAATTGATAGCATTATTA ACAAATCAATCAACAACAAAGTTTATAGAGGAAAATATAATAAATCCATTTAATTTATCT GATGGTATAAAAATGTATTTACCTGATTATAGCTTAAATAATGACCAAGTAAGTATTTTT CAATCTGAAAAGTATGATGAAACAAATATTGGGGCTAATAATAATAACAACAAGTTCTTA TTTCCTTTATTTTCCCCACGTTCTTCATCTTCATCATCATTTTTTGCTCAAGAAGAATTT TCTTCAAGTATAATGAGATTATCAAATATTAAAAGTAAATTAGAAAATAGTAATGGTACT CAATTAATGAATGAAATAAAAGATATAATAATTCAAAAGTTAACCCCAAAAAGAATAAGC AAGGAAGAAAAAGAAAAAGAGAAAGAGAAGGAAAAAAATATTAATGATTATAATGAAGAA GATAATAATGATGAGAATATTAATATAATTGATTTTTATGAAAGATATGCAATGGTAAAT CGAAAAATGGAGTTTTCTTCAATATCTTTTAAACAAGTACTTGAAAAACTTAAATCATCT GACTTATATAAATTAAAAAATTATGGTTATCAAGATTTTAACAAAACAAAAATCAATTTG AAATTATCAACCTTAGAGTATTTTTTTTTAAAACCAGATATATTAGATCCCTTAATATAT AATTCAAAAAAATTAATAAATAAATGGATACCACCAACAAATGGAAGATATACATCTTTA TCATTAGCAAAATTATATAATCACTTAATTAGAGGAGAGATTATAGGAGATAAATTATTA AAACAAGTTATTAAAAATGAATCAATTACTTTTGATAATTCTATCGAAGGATTAATATTA ACATATGGAGGTCCTAGAAAATGGTCTCTTGGGTTTCAAATTTTAGAATGTAAAAAAATT TATTATCATCAAAATAATCAAAAAGATGATGATCAACCTTGTTTTAAAGGAATTGGTCAA TCTGATACTGGTGGTAATTTATCATTTTGTTTTCCAGAAATTGATTTATCTATTGCCATT CTAACAAATGATTATGTTAAAGGATCTTATATATCACAATCAATATTACGTTACATATTA GAAAACTTTGGATTATATTTGAACAATTATGTTCCATTATATTTTTCTTAG
  • Download Fasta

  • Fasta :-

    MKSRQINDLNLMDCWPNDIIYFVRILLLLRGICAELNESIPILKILSRRAQQFLYLESIN LELNKQQLLKRRFTNKFERRLSDYIEKIMNENMVWGYNXAIIKNGKXLVNISKGIKGELN GNQIDENTLFNGFFINLGILVIAILICVEKGYISLDDPICHYWDGFIRYGKRNITLRHVL DHRSGVISFFPKDMGLKELLNYEKMIQIIEDSAPQVPINQITRYNPYFLGWILSELIALL TNQSTTKFIEENIINPFNLSDGIKMYLPDYSLNNDQVSIFQSEKYDETNIGANNNNNKFL FPLFSPRSSSSSSFFAQEEFSSSIMRLSNIKSKLENSNGTQLMNEIKDIIIQKLTPKRIS KEEKEKEKEKEKNINDYNEEDNNDENINIIDFYERYAMVNRKMEFSSISFKQVLEKLKSS DLYKLKNYGYQDFNKTKINLKLSTLEYFFLKPDILDPLIYNSKKLINKWIPPTNGRYTSL SLAKLYNHLIRGEIIGDKLLKQVIKNESITFDNSIEGLILTYGGPRKWSLGFQILECKKI YYHQNNQKDDDQPCFKGIGQSDTGGNLSFCFPEIDLSIAILTNDYVKGSYISQSILRYIL ENFGLYLNNYVPLYFS

    No Results
No Results
No Results
IDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethodIDSitePeptideScoreMethod
Chro.50137360 SPKRISKEEK0.998unspChro.50137360 SPKRISKEEK0.998unspChro.50137360 SPKRISKEEK0.998unspChro.5013782 SERRLSDYIE0.996unspChro.50137309 SSPRSSSSSS0.995unsp

Chro.50137      



Dinesh Gupta lab Translational bioinformatics group, ICGEB, New Delhi, India